WO2019059265A1 - Method for manufacture of microneedle and microneedle - Google Patents

Method for manufacture of microneedle and microneedle Download PDF

Info

Publication number
WO2019059265A1
WO2019059265A1 PCT/JP2018/034766 JP2018034766W WO2019059265A1 WO 2019059265 A1 WO2019059265 A1 WO 2019059265A1 JP 2018034766 W JP2018034766 W JP 2018034766W WO 2019059265 A1 WO2019059265 A1 WO 2019059265A1
Authority
WO
WIPO (PCT)
Prior art keywords
microneedle
hole
needle
filling liquid
sheet
Prior art date
Application number
PCT/JP2018/034766
Other languages
French (fr)
Japanese (ja)
Inventor
邦男 宮地
及川 陽一
耕平 豊田
Original Assignee
シンクランド株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シンクランド株式会社 filed Critical シンクランド株式会社
Priority to JP2019543695A priority Critical patent/JPWO2019059265A1/en
Publication of WO2019059265A1 publication Critical patent/WO2019059265A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Definitions

  • the present invention is suitable, for example, for a method of manufacturing a hollow type microneedle using a bioabsorbable polymer material or a metal / ceramic material.
  • microneedles described above microneedle the target substances as they are, hollow microneedles are required because the usable target substances are limited.
  • the present invention has been made to solve such problems, and its object is to provide a method of manufacturing a hollow type microneedle and a microneedle.
  • a sheet shape is formed in which a plurality of needle piles are formed, and a through hole penetrating from the vertex or apex vicinity of each needle pile to the back of the sheet is formed.
  • the through hole end of the microneedle is brought into contact with the filling liquid, and the through hole is filled with the filling liquid by capillary action.
  • the microneedle of the present invention is A plurality of needle piles are formed, and a through hole penetrating from the vertex or apex vicinity of each needle pile to the back surface of the sheet is formed, and the through hole is filled with the filling liquid
  • h height of through hole
  • T surface tension (N / m)
  • contact angle between filling solution and inner surface of through hole (°)
  • g gravitational acceleration (Height of square of 9.80665 m / s)
  • r inner diameter of tube (radius: mm)
  • height h of capillary phenomenon expressed as equation (1) is 70% of height Hh of the through hole More than It is characterized by
  • the present invention can realize a microneedle manufacturing method and a microneedle capable of easily manufacturing a hollow type microneedle.
  • FIG. 5 is a schematic diagram for describing the filling of the filling liquid from the back side of the sheet. It is a basic diagram which shows the structure of the through-hole provided in the side of a needle track.
  • microneedles consisting of microprojections with a small diameter have been proposed for the purpose of injecting a cosmetic component or drug as a target substance into the skin so as not to damage the skin as much as possible (for example, patent 5495034)).
  • the microneedles are formed by transferring a pattern using a mold such as a mold.
  • the microneedle itself contains the target substance, and the microneedle stuck in the skin is absorbed into the body as it is.
  • the types and amounts of target substances that can be contained in the microneedles For example, it is difficult to use a liquid or semi-solid substance at normal temperature.
  • the microneedles have a fine structure, it is not easy to fill the holes with the filling liquid even if the holes are formed.
  • the inventors of the present invention have found a method of manufacturing a microneedle in which a hole is formed in the microneedle and a target substance is injected into the body through the hole.
  • FIG. 1 (A) in the microneedle 1 of the present invention, a plurality of needle ridges 3 projecting from the sheet surface 2A which is the surface side of the base sheet 2 are formed.
  • FIG. 1B shows a cross-sectional view of the microneedle 1.
  • Each needle thread 3 is formed with a through hole 4 penetrating from the vicinity of the vertex 3A or the vertex 3A to the back surface 2B.
  • the thickness of the substrate sheet 2 is not particularly limited, but is preferably 10 ⁇ m or more and 300 ⁇ m or less. When the base sheet 2 is too thin, it is difficult to obtain sufficient rigidity physically, and when it is too thick, the through hole height Hh which is the height of the through hole 4 becomes too large.
  • the needle height Hn from the sheet surface 2A to the apex 3A is about 30 to 500 ⁇ m. If it is smaller than 30 ⁇ m, the apex 3A of the needle peak 3 can not reach the skin to a sufficient depth, and if it is 500 ⁇ m or more, it is difficult to obtain sufficient structural strength.
  • the radius of the through hole 4 is not particularly limited, but is preferably 1 ⁇ m or more and 30 ⁇ m or less. If the radius is too small, the volume that can be filled in the through hole 4 becomes too small, and if the radius is too large, the physical strength required as the needle crest 3 can not be maintained, which is not preferable.
  • the material of the base sheet 2 and the needle pile 3 is not particularly limited, but for example, various inorganic materials such as metals such as aluminum and stainless alloys, silicon, carbon, ceramics, various mineral materials including calcium based minerals, and organic materials A high molecular compound etc. can be used suitably as a main component.
  • various inorganic materials such as metals such as aluminum and stainless alloys, silicon, carbon, ceramics, various mineral materials including calcium based minerals, and organic materials
  • a high molecular compound etc. can be used suitably as a main component.
  • a bioabsorbable material which is harmless to the human body and which is absorbed by adjustment.
  • the polymer compound means an organic compound having a weight average molecular weight Mw of 5000 or more.
  • the main component means that the polymer compound is 50% by weight or more of the whole workpiece.
  • Tg glass transition point
  • Tg is 50 degreeC or more, More preferably, it is 70 degreeC or more. If the Tg is low, handling at normal temperature becomes difficult.
  • the ratio of this main component is the weight after the completion of the whole processing process of a to-be-processed object, and does not contain what is called a solvent component which evaporates intentionally at the drying process after formation of microprotrusion. That is, it is the ratio after the end of processing of the workpiece.
  • polymer compound known compounds (synthetic polymers and natural polymers) can be used.
  • synthetic polymers and natural polymers can be used.
  • plastic materials such as PET (polyethylene terephthalate), polyethylene, polypropylene, acrylic resin, epoxy resin, polystyrene, etc.
  • bioabsorbable polymers can be used.
  • ester compounds such as polylactic acid, polyglycolic acid, poly- ⁇ caprolactone, poly-rho-dioxane, polymalic acid, acid anhydrides such as polyacid anhydride, ortho ester compounds such as polyorthoester, carbonates such as polycarbonate Compounds, phosphazene compounds such as polydiaminophosphazenes, peptide compounds such as synthetic polypeptides, phosphate ester compounds such as polyphosphoester urethanes, carbon-carbon compounds such as polycyanoacrylates, poly- ⁇ -hydroxybutyric acid, polymalic acid, etc.
  • ester compounds such as polylactic acid, polyglycolic acid, poly- ⁇ caprolactone, poly-rho-dioxane, polymalic acid, acid anhydrides such as polyacid anhydride, ortho ester compounds such as polyorthoester, carbonates such as polycarbonate Compounds, phosphazene compounds such as polydia
  • Gum arabic Polysaccharides
  • Collagen Collagen
  • Gelatin Fibrin
  • the same material may be used as the material of the base sheet 2 and the needle pile 3, and different materials may be used.
  • the same material is used when forming the needle pile 3 by scraping the base sheet 2 or the like, and when forming the needle pile 3 by molding or the like on the base sheet 2, another material or the same material is used.
  • the material is appropriately selected.
  • the through hole 4 is formed after the needle peak 3 is formed on the base sheet 2.
  • various methods such as irradiation of a circularly polarized light vortex laser beam to the substrate sheet 2, molding, etching, ion milling and the like can be used.
  • the through holes 4 are formed by, for example, a method such as laser irradiation or fine hole processing using a micro drill.
  • the needle head 3 and the through hole 4 can be simultaneously formed.
  • a mold 11 having a microneedle transfer pattern, a rod member 15 and a spacer 19 are used.
  • the mold 11 has a protrusion concave portion 12 which is a transfer pattern of a microneedle, and a through hole 4 which leads to the protrusion concave portion 12 and leads to the bottom surface of the mold 11 (opposite surface of the protrusion concave portion 12).
  • the through holes 4 are provided one by one for all the projection recesses 12.
  • the rod-like member 15 has a plurality of rod portions 16 formed in accordance with the position of the through holes 4 and a flat plate portion 17, and is fixed so that the rod portions 16 project from the plate portion 17. ing.
  • the spacer 19 exists in a free state that can be removed from the rod-like member 15 and the mold 11.
  • the rod-shaped member 15 is inserted into the mold 11, and the spacer 19 is sandwiched between the rod-shaped member 15 and the mold 11. As a result, the rod-shaped member 15 penetrates the through hole 4 of the mold 11 and protrudes from the mold 11 while leaving a certain gap space between the rod-shaped member 15 and the mold 11.
  • the base sheet 2 is filled into the mold 11 in which the rod-like member 15 is inserted.
  • the method of solidification there is no particular limitation on the method of solidification in which the substrate sheet 2 is filled in a liquid or semi-liquid state, and the substrate sheet 2 which has been heated and liquefied is cooled, and the low molecular weight substrate sheet 2 is used.
  • the base sheet 2 is solidified by curing, crystallization, evaporation of solvent components and the like caused by a chemical reaction (polymerization) with a crosslinking agent and a curing agent.
  • the substrate sheet 2 is released from the mold 11 and becomes a molded article.
  • the substrate sheet 2 may be deformed or the rod portion 16 may be broken, so the rod-like member 15 is pulled out. Then, the substrate sheet 2 is released.
  • the spacer 19 is removed first, and the rod-shaped member 15 is moved to the mold 11 side, and then the rod-shaped member 15 is pulled out from the mold 11. Then, as shown in FIG. 6, the microneedle 1 can be manufactured by releasing the base sheet 2 from the mold 11.
  • the through holes 112 and 114 are respectively formed in the plate-like pedestal plates 111 and 113.
  • the base plates 111 and 113 constitute the base sheet 2 in the microneedle 1 as a molded product, and the material thereof is not limited.
  • the rod portion 116 of the rod-like member 115 is penetrated so as to pierce the workpiece 120, and as shown in FIG. 9, the base plate 103 is slowly pulled up (or the base plate 101 is pulled down).
  • the upper and lower (root) portions in the vicinity of the pedestal plates 111 and 113 become thicker, while the vicinity of the center becomes thinner.
  • the workpiece 110 is solidified, and after pulling out the rod-like member 105, the microneedle 1 can be manufactured as shown in FIG.
  • the rod member 105 can be pulled out after the base plate 103 is pulled up to solidify the workpiece until the central portion is broken.
  • the filling liquid tank 8 holding the end 4A or 4B of the through hole 4 of the sheet-like microneedle 1 is brought into contact, and the filling liquid 9 is filled in the through hole 4 by capillary action. To fill.
  • the height at which capillary action occurs is represented by equation (1).
  • h height of capillary action
  • T surface tension (N / m)
  • contact angle between filling liquid and inner surface of through hole (°)
  • ° density of filling liquid (kg / m 3)
  • g Gravity acceleration (9.80665 m / s squared)
  • r inside diameter of tube (radius: mm)
  • the through hole 4 is filled with the filling liquid 9 at a filling rate of approximately 100%.
  • the filling rate is not necessarily 100%, it is preferable that a large amount of filling liquid 9 which is the target substance be filled.
  • the filling rate is low, the position of the filling liquid 9 is biased to form a cavity, which may make it difficult for the filling liquid 9 to be taken into the body from the skin. Therefore, it is preferable that the through hole height Hh ⁇ the height h ⁇ 70% of the capillary phenomenon.
  • the through hole height Hh is preferably 50 ⁇ m or more and less than 1000 ⁇ m. If the through hole height Hh is too small, the distance from the skin surface reached by the tip of the needle pile 3 is not sufficient. If the through hole height Hh is too large, the strength of the needle pile 3 may be insufficient.
  • the filling liquid 9 is not particularly limited, but is a liquid, a drug obtained by liquefying a pharmaceutically active ingredient used as various medicines such as insulin, hormone agent, antibody, vaccine, collagen, hyaluronic acid Cosmetic solutions obtained by liquefying various cosmetic components such as, and nutrient solutions obtained by liquefying various nutritional components such as glucose and vitamins are preferably used.
  • the viscosity (25 ° C., 60 rpm, L-type viscometer) of the filling liquid 9 is preferably 0.5 mPa ⁇ s or more and 500 mPa ⁇ s or less, more preferably 0.8 mPa ⁇ s or more and 200 mPa ⁇ s or less. If the viscosity is too low, the stability of the filling liquid 9 against impact or the like will decrease, and if the viscosity is too high, it is not preferable because the capillary phenomenon hardly occurs.
  • the protective material 50 has a support portion 51 for supporting the flat portion 2 ⁇ / b> C where the needle peak 3 is not formed in the base sheet 2, and a bottom surface 52.
  • the support portion 51 is in contact with the flat portion 2C, and the depth D of the support portion 51 is formed higher than the height Hn of the needle head 3, and prevents any contact with the apex of the through hole 4. Thereby, it can prevent that the filling liquid 9 in the through-hole 4 leaks outside.
  • the top surface 52 is not necessarily required, and part or all of the bottom surface 52 may be open. There is no restriction in the vertical direction in the microneedle 1 and the protective material 50, and the vertical direction may be reversed (in this case, the bottom surface 52 is the top surface).
  • the through hole 4 offset (shifted) from the vertex of the needle peak 3 (see FIG. 10)
  • the height of the needle peak 3 can be maintained, and the tip of the through hole 4 in the needle peak 3 to the vertex
  • the area serves to protect the through hole 4.
  • it may be offset from the top of the needle head 3 and inclined in the opposite direction to the offset direction of the through hole 4.
  • the volume inside the through hole 4 can be increased by the amount of inclination, and the physical strength of the needle peak 3 can be maintained by increasing the distance from the surface of the needle peak 3 to the through hole 4 as much as possible.
  • the microneedle 1 thus formed is used by piercing the apex 3A on the skin.
  • the filling liquid 9 inside the through hole 4 comes in contact with the body fluid, so it is pulled by the body fluid by surface tension and absorbed into the body.
  • the needle pile 3 itself can be absorbed into the body by leaving the microneedle 1 stuck to the skin as it is.
  • a through-hole with a diameter of 20 ⁇ m is formed in a 300 ⁇ m-thick flat plate made of sodium hyaluronate (hyaluronic acid 85 wt%, water 15 wt%), and red dye solution (water 0.5 ml with 0.015 g When dissolved and diluted with 5 ml of ethanol was brought into contact with one side of a flat plate, the red dye solution was filled in the through hole and it was confirmed by experiment that the filled state is maintained as it is .
  • sodium hyaluronate hyaluronic acid 85 wt%, water 15 wt%
  • red dye solution water 0.5 ml with 0.015 g
  • a plurality of needle piles are formed, and they are penetrated from the sheet surface (sheet front surface 2A) side where the needle piles are formed to the sheet back surface (sheet back surface 2B) side
  • the end of the through hole of the sheet-like microneedle (microneedle 1) in which the through hole (through hole 4) is formed is brought into contact with the filling liquid (filling liquid 9), and the through hole is filled with the filling liquid Do.
  • seat surface side means all the surfaces which united the needle-peak part and the plane part in which the needle-peak is not formed.
  • the filling liquid can be filled by a simple method, and the manufacture of the microneedle can be simplified.
  • h height of capillary action
  • T surface tension (N / m)
  • contact angle between filling liquid and inner surface of through hole (°)
  • density of filling liquid (kg / m 3)
  • g gravitational acceleration (Height of square of 9.80665 m / s)
  • r inner diameter of tube (radius: mm)
  • the height h of the capillary phenomenon expressed as the equation (1) is 70% or more of the through hole height Hh is there
  • the filling rate of the filling liquid to be filled in the through hole 4 can be increased, and the void (air content) rate in the through hole 4 can be reduced to improve the continuity.
  • the filling liquid can be injected smoothly without stopping by air.
  • the portion contacting the filling liquid is reduced compared to the method in which the back side of the sheet is in contact with the filling liquid, and excess filling liquid is deposited It is not necessary.
  • the microneedle is characterized in that the through hole is formed by using a laser which is irradiated from the tip direction of the needle pile to the needle pile.
  • the through hole can be formed easily and quickly with an arbitrary diameter, and the component melted by the laser is attached to the periphery of the through hole to form a bulge, and the bulge makes contact with the outside. Since it can prevent, it can play a role which protects the filling liquid inside a through-hole.
  • the microneedle is characterized in that the through hole is formed by pulling out a rod-like member which has been penetrated in advance when forming the needle peak, and the rod-like member is drawn in the direction of the root of the needle peak.
  • the root portion is swelled, and contact with the outside can be prevented by the swell, which can play a role of protecting the filling liquid in the through hole.
  • the apexes can play a role in protecting the through holes.
  • the amount of offset is not limited, the strength in the vicinity of the tip of the needle peak can be maintained by securing the offset amount of 1 ⁇ 4 or more of the radius of the needle tip. Also, by setting the radius of the needle to less than 2.0 times, more preferably less than 1.5 times, it is possible to reliably introduce the filling solution into the skin.
  • the offset amount is a plane distance (a distance parallel to a plane portion of the sheet surface) from the needle peak to the center of the through hole.
  • the radius of the needle peak is the distance from the intersection of the ridge line along the slope portion from the needle peak and the plane line extending the plane of the sheet surface to the needle peak. If the needle peak is not at the perfect center position of the needle peak, the average value is regarded as the radius.
  • a microneedle suitable for injection into the skin can be provided.
  • the viscosity of the filling liquid is 0.5 mPa ⁇ s or more and 500 mPa ⁇ s or less, the filling liquid can be stably held inside the through hole while causing capillary phenomenon.
  • the through hole is formed in the vicinity of the root portion of the needle peak. As a result, since it is sufficient to provide the through hole in the flat portion where the needle pile is not formed, the strength of the needle pile can be maintained.
  • Protective material having a facing surface facing the sheet and a supporting portion (supporting portion 51) which is formed to protrude from the facing surface and is formed to be higher than the needle peak height from the sheet surface to the top of the needle peak 50), It arrange
  • the microneedle can be appropriately protected so that the tip of the through hole does not contact.
  • the two ends of the through hole are open, which can simplify the manufacturing process.
  • the microneedle pierces the skin at the top of the needle peak and contacts the body fluid inside the skin, thereby using surface tension to absorb the filling fluid into the body.
  • the microneedle can absorb the target substance into the user's body in a simple procedure without requiring special pressurization or the like.
  • the protective material 150 is provided with a hole 155 penetrating between the support portions 150 at or near the bottom portion of the support portion 151.
  • a filling solution 9 such as a cosmetic solution, a cosmetic solution, or a special solution which is separately attached to the protective material 150 or held by the user, the entire area of the protective material 150 is formed through the holes 155.
  • the filling liquid 9 spreads to form the filling liquid tank 8.
  • the depth D of the support portion 151 in the protective material 150 is formed slightly larger than the height Hh of the needle head 3 (for example, 0.05 to 0.5 mm). Therefore, just by the user pouring the filling liquid 9 into the protective material 150 and mounting the microneedle 1, the apex 3A of the needle pile 3 is positioned without coming into contact with the bottom surface 152, and the user can easily fill the apex 3A with the filling liquid
  • the filling liquid 9 can be filled in the through hole 4 of the microneedle 1 by contacting the tank 8.
  • the depth D of the support portion 151 in the protective material 150 is formed to be slightly larger than the height Hh of the needle head 3, and a hole is provided in the hole or the support portion 151 so that the liquid can move between the support portions 151.
  • the filling liquid 9 can be spread over the entire area of the protective material 151 to form the filling liquid tank 8, and the position of the apex 3A is positioned slightly above the bottom surface 152 by the support portion 151, and filling is performed by capillary action.
  • the liquid 9 can be easily filled.
  • the filling liquid 9 can be sucked up from the back surface 2 B side of the microneedle 1.
  • a predetermined amount of filling liquid is dropped near the center of the flat tray 250, and this is used as the filling tank 8.
  • the filling tank 8 spreads over the entire area of the microneedle 1, and the inside of the through hole 4 can be filled with the filling liquid 9 by capillary action.
  • the tray 250 may be used as a protective material for protecting the tip 3A of the microneedle 1, and may be separately attached or sold separately.
  • the offset amount from the vicinity of the root portion of the needle head 2, that is, the offset from the tip of the needle head is larger than the radius of the needle head 2 and less than twice the radius of the needle head 2, more preferably 1.5 times
  • a through hole is formed immediately next to the needle pile.
  • the filling liquid filled in the through hole 4X can be supplied where the skin is scratched by the needle head 2. Therefore, the same effect as in the case where the through hole is provided in the needle head Penetration) can be obtained.
  • the through holes 4X can be formed before or after the formation of the needle pile, or simultaneously with the needle pile. When a needle pile is formed by molding, a through hole may be provided at a position where there is no needle pile in the mold, and the rod-like member may be penetrated.
  • the filling liquid 9 can be filled by dropping the filling liquid onto the back surface 2B of the microneedle 1 and spreading it using a spatula or the like.
  • the present invention can be applied to microneedles, for example in injection applications.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

[Problem] To enable filling of a hollow microneedle with a fill liquid through a simple method and easy manufacturing of a microneedle having a hollow needle filled with a fill liquid. [Solution] According to this method for microneedle manufacture, multiple tapered-cone needles 3 are formed on a sheetlike microneedle 1, a through-hole 4 is formed at either the apex 3A or the vicinity of the apex 3A of each tapered-cone needle and penetrates to the reverse face 2B of the sheet, the ends of the through-holes on the sheetlike microneedle 1 are brought into contact with a fill liquid 9, and the through-holes are filled with the fill liquid through capillary action.

Description

マイクロニードルの製造方法及びマイクロニードルMicroneedle manufacturing method and microneedle
 本発明は、例えば生体吸収高分子材料や金属・セラミック材料を使用した中空タイプのマイクロニードルの製造方法に好適なものである。 The present invention is suitable, for example, for a method of manufacturing a hollow type microneedle using a bioabsorbable polymer material or a metal / ceramic material.
 近年、美容目的などで、生体吸収高分子などの高分子化合物を使用したマイクロニードルが広く知られている。(例えば特許文献1参照)。 In recent years, microneedles using polymer compounds such as bioabsorbable polymers are widely known for cosmetic purposes and the like. (See, for example, Patent Document 1).
特許第5495034号Patent No. 5495034
 しかしながら、上述したマイクロニードルは、目的物質をそのままマイクロニードル化するため、使用可能な目的物質に制限があるため、中空タイプのマイクロニードルが要望されている。 However, since the microneedles described above microneedle the target substances as they are, hollow microneedles are required because the usable target substances are limited.
 本発明はこのような問題を解決するためになされたもので、その目的は、中空タイプのマイクロニードルの製造方法及びマイクロニードルを提供するものである。 The present invention has been made to solve such problems, and its object is to provide a method of manufacturing a hollow type microneedle and a microneedle.
 かかる課題を解決するため、本発明のマイクロニードルの製造方法は、 複数の針山が形成されており、それぞれの針山の頂点又は頂点近傍からシート裏面までを貫通する貫通孔が形成されているシート状のマイクロニードルの貫通孔端部を充填液に接触させ、毛細管現象によって貫通孔に充填液を充填することを特徴とする。 In order to solve such problems, in the method of manufacturing a microneedle according to the present invention, a sheet shape is formed in which a plurality of needle piles are formed, and a through hole penetrating from the vertex or apex vicinity of each needle pile to the back of the sheet is formed. The through hole end of the microneedle is brought into contact with the filling liquid, and the through hole is filled with the filling liquid by capillary action.
 また、本発明のマイクロニードルは、
 複数の針山が形成されており、それぞれの針山の頂点又は頂点近傍からシート裏面までを貫通する貫通孔が形成されており、貫通孔内には充填液が充填されており、
 h=貫通孔の高さ、T=表面張力(N/m)、θ=充填液と貫通孔内面との接触角(°)、ρ=充填液の密度(kg/m3)、g=重力加速度(9.80665m/sの2乗)、r=管の内径(半径:mm)としたとき、式(1)として表される毛細管現象の高さhは、前記貫通孔の高さHhの70%以上である
Figure JPOXMLDOC01-appb-I000003
ことを特徴とする。
Moreover, the microneedle of the present invention is
A plurality of needle piles are formed, and a through hole penetrating from the vertex or apex vicinity of each needle pile to the back surface of the sheet is formed, and the through hole is filled with the filling liquid,
h = height of through hole, T = surface tension (N / m), θ = contact angle between filling solution and inner surface of through hole (°), = = density of filling solution (kg / m 3), g = gravitational acceleration (Height of square of 9.80665 m / s), r = inner diameter of tube (radius: mm), height h of capillary phenomenon expressed as equation (1) is 70% of height Hh of the through hole More than
Figure JPOXMLDOC01-appb-I000003
It is characterized by
 本発明は、中空タイプのマイクロニードルを簡易に製造できるマイクロニードルの製造方法及びマイクロニードルを実現できる。 The present invention can realize a microneedle manufacturing method and a microneedle capable of easily manufacturing a hollow type microneedle.
マイクロニードルの構成を示す概略図である。It is the schematic which shows the structure of a microneedle. マイクロニードルの製造方法(1)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (1) of a microneedle. マイクロニードルの製造方法(2)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (2) of a microneedle. マイクロニードルの製造方法(3)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (3) of a microneedle. マイクロニードルの製造方法(4)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (4) of a microneedle. マイクロニードルの製造方法(5)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (5) of a microneedle. マイクロニードルの製造方法(6)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (6) of a microneedle. マイクロニードルの製造方法(7)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (7) of a microneedle. マイクロニードルの製造方法(8)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (8) of a microneedle. マイクロニードルの製造方法(9)の説明に供する概略図である。It is the schematic where it uses for description of the manufacturing method (9) of a microneedle. 充填液の充填の説明に供する略線図である。It is a schematic diagram by which it uses for description of filling of a filling liquid. 保護材の配置の説明に供する略線図である。It is a schematic diagram by which it uses for description of arrangement | positioning of a protective material. 保護材の配置及び充填液の充填の説明に供する略線図である。It is a schematic diagram by which it uses for description of arrangement | positioning of a protective material, and filling of a filling liquid. シート裏面からの充填液の充填の説明に供する略線図である。FIG. 5 is a schematic diagram for describing the filling of the filling liquid from the back side of the sheet. 針山の横に設けられた貫通孔の構成を示す略線図である。It is a basic diagram which shows the structure of the through-hole provided in the side of a needle track.
<第1の実施の形態>
 以下、本発明を実施するための形態について図面を参照して説明する。
First Embodiment
Hereinafter, embodiments of the present invention will be described with reference to the drawings.
 近年、美容や医療用途において、皮膚をできるだけ傷付けないように目的物質である美容成分や薬剤を皮膚に注入することを目的として、直径が小さい微小突起でなるマイクロニードルが提案されている(例えば特許第5495034号参照)。このマイクロニードルは、金型などのモールド型を使用してパターンを転写することにより形成される。 In recent years, in cosmetic and medical applications, microneedles consisting of microprojections with a small diameter have been proposed for the purpose of injecting a cosmetic component or drug as a target substance into the skin so as not to damage the skin as much as possible (for example, patent 5495034)). The microneedles are formed by transferring a pattern using a mold such as a mold.
 このマイクロニードルでは、マイクロニードルそのものが目的物質を含んでおり、皮膚に刺さったマイクロニードルがそのまま体内に吸収される。しかしながら、マイクロニードルに含有させることができる目的物質の種類や量に制限がある。例えば、常温で液体や半固体状の物質を使用することが困難である。 In this microneedle, the microneedle itself contains the target substance, and the microneedle stuck in the skin is absorbed into the body as it is. However, there are limitations on the types and amounts of target substances that can be contained in the microneedles. For example, it is difficult to use a liquid or semi-solid substance at normal temperature.
 しかしながら、マイクロニードルは微細な構造を有しているため、孔を形成したとしても該孔に充填液を充填することは容易ではない。 However, since the microneedles have a fine structure, it is not easy to fill the holes with the filling liquid even if the holes are formed.
 本願発明人は、マイクロニードルに孔を形成し、当該孔を通じて目的物質を体内に注入するマイクロニードルの製造方法を見出した。 The inventors of the present invention have found a method of manufacturing a microneedle in which a hole is formed in the microneedle and a target substance is injected into the body through the hole.
 図1(A)に示すように、本願発明のマイクロニードル1は、基材シート2の表面側であるシート表面2Aから突出する複数の針山3が形成されている。図1(B)には、マイクロニードル1の断面図を示している。それぞれの針山3には、頂点3A又は頂点3A近傍からシート裏面2Bまでを貫通する貫通孔4が形成されている。 As shown in FIG. 1 (A), in the microneedle 1 of the present invention, a plurality of needle ridges 3 projecting from the sheet surface 2A which is the surface side of the base sheet 2 are formed. FIG. 1B shows a cross-sectional view of the microneedle 1. Each needle thread 3 is formed with a through hole 4 penetrating from the vicinity of the vertex 3A or the vertex 3A to the back surface 2B.
 基材シート2の厚みとしては、特に制限はないが、10μm以上、300μm以下であることが好ましい。基材シート2が薄すぎると物理的に十分な剛性を得ることが困難で有り、厚すぎると、貫通孔4の高さである貫通孔高さHhが大きくなりすぎるからである。 The thickness of the substrate sheet 2 is not particularly limited, but is preferably 10 μm or more and 300 μm or less. When the base sheet 2 is too thin, it is difficult to obtain sufficient rigidity physically, and when it is too thick, the through hole height Hh which is the height of the through hole 4 becomes too large.
 針山としては、シート表面2Aから頂点3Aまでの針山高さHnが30~500μm程度であることが好ましい。30μmよりも小さいと、皮膚に対して十分な深度まで針山3の頂点3Aが到達できず、500μm以上になると構造上の強度を十分に得ることが困難となるため、好ましくない。 It is preferable that the needle height Hn from the sheet surface 2A to the apex 3A is about 30 to 500 μm. If it is smaller than 30 μm, the apex 3A of the needle peak 3 can not reach the skin to a sufficient depth, and if it is 500 μm or more, it is difficult to obtain sufficient structural strength.
 貫通孔4の半径としては、特に制限はないが、1μm以上、30μm以下であることが好ましい。半径が小さすぎると、貫通孔4に充填可能な容量が小さくなりすぎ、半径が大きすぎると、針山3として必要な物理的強度が保てなくなるため、好ましくない。 The radius of the through hole 4 is not particularly limited, but is preferably 1 μm or more and 30 μm or less. If the radius is too small, the volume that can be filled in the through hole 4 becomes too small, and if the radius is too large, the physical strength required as the needle crest 3 can not be maintained, which is not preferable.
 基材シート2及び針山3の材料としては、特に限定されないが、例えばアルミニウムやステンレス合金などの金属、シリコン、カーボン、セラミック、カルシウム系鉱物を含む各種鉱物材料などの各種無機材料や、有機系の高分子化合物などを主成分として好適に使用することができる。特に医療や美容用途で使用される場合、基材シート2の材料としては、人体に無害であり、整体に吸収される生体吸収材料が使用されることが好ましい。 The material of the base sheet 2 and the needle pile 3 is not particularly limited, but for example, various inorganic materials such as metals such as aluminum and stainless alloys, silicon, carbon, ceramics, various mineral materials including calcium based minerals, and organic materials A high molecular compound etc. can be used suitably as a main component. In particular, when used for medical and cosmetic applications, it is preferable to use, as the material of the base sheet 2, a bioabsorbable material which is harmless to the human body and which is absorbed by adjustment.
 本明細書において、高分子化合物とは、量平均分子量Mwが5000以上の有機化合物を意味する。主成分とは、高分子化合物が被加工物全体の50重量%以上であることを意味する。高分子化合物としては、Tg(ガラス転移点)が50℃以上、より好ましくは70℃以上であることが好ましい。Tgが低いと、常温での取り扱いがしづらくなるからである。 In the present specification, the polymer compound means an organic compound having a weight average molecular weight Mw of 5000 or more. The main component means that the polymer compound is 50% by weight or more of the whole workpiece. As a high molecular compound, it is preferable that Tg (glass transition point) is 50 degreeC or more, More preferably, it is 70 degreeC or more. If the Tg is low, handling at normal temperature becomes difficult.
 高分子化合物としては、1種類のみ含有しても良く、2種類以上混合しても良い。なお、この主成分の割合は、被加工物の全加工工程終了後の重量であり、微少突起の形成後の乾燥工程で意図して蒸発させる、いわゆる溶媒成分を含まない。すなわち、被加工物の加工終了後における割合である。 As a high molecular compound, only 1 type may be contained and 2 or more types may be mixed. In addition, the ratio of this main component is the weight after the completion of the whole processing process of a to-be-processed object, and does not contain what is called a solvent component which evaporates intentionally at the drying process after formation of microprotrusion. That is, it is the ratio after the end of processing of the workpiece.
 高分子化合物としては、既知の化合物(合成高分子及び天然高分子)を使用することができる。例えばPET(ポリエチレンテレフタレート)や、ポリエチレン、ポリプロピレン、アクリル樹脂、エポキシ樹脂、ポリスチレンなど、種々のプラスチック材料の他、生体吸収高分子を使用することができる。 As the polymer compound, known compounds (synthetic polymers and natural polymers) can be used. For example, in addition to various plastic materials such as PET (polyethylene terephthalate), polyethylene, polypropylene, acrylic resin, epoxy resin, polystyrene, etc., bioabsorbable polymers can be used.
 生体吸収高分子としては、既知の化合物(合成高分子及び天然高分子)を使用することができる。例えば、ポリ乳酸、ポリグリコール酸、ポリ-εカプロラクトン、ポリ-ρ-ジオキサン、ポリリンゴ酸などのエステル化合物、ポリ酸無水物などの酸無水物、ポリオルソエステルなどのオルソエステル化合物、ポリカーボネートなどのカーボネート化合物、ポリジアミノホスファゼンなどのホスファゼン化合物、合成ポリペプチドなどのペプチド化合物、ポリホスホエステルウレタンなどのリン酸エステル化合物、ポリシアノアクリレートなどの炭素-炭素化合物、ポリ-β-ヒドロキシ酪酸、ポリリンゴ酸などのエステル化合物、ポリアミノ酸、キチン、キトサン、ヒアルロン酸、ヒアルロン酸ナトリウム、ペクチン酸、ガラクタン、デンプン、デキストラン、デキストリン、アルギン酸、アルギン酸ナトリウム、セルロース化合物(エチルセルロース、カルボキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース)、ゼラチン、寒天、ケルトロール、レオザン、キサンタンガム、プルラン、アラビアゴムなどのグリコシド化合物(多糖類)、コラーゲン、ゼラチン、フィブリン、グルテン、血清アルブミンなどのペプチド化合物(ペプチド、タンパク質)、デオキシリボ核酸、リボ核酸などのリン酸エステル化合物(核酸)、ポリビニルアルコールなどのビニル化合物などが挙げられる。 Known compounds (synthetic polymers and natural polymers) can be used as bioabsorbable polymers. For example, ester compounds such as polylactic acid, polyglycolic acid, poly-ε caprolactone, poly-rho-dioxane, polymalic acid, acid anhydrides such as polyacid anhydride, ortho ester compounds such as polyorthoester, carbonates such as polycarbonate Compounds, phosphazene compounds such as polydiaminophosphazenes, peptide compounds such as synthetic polypeptides, phosphate ester compounds such as polyphosphoester urethanes, carbon-carbon compounds such as polycyanoacrylates, poly-β-hydroxybutyric acid, polymalic acid, etc. Ester compounds, polyamino acids, chitin, chitosan, hyaluronic acid, sodium hyaluronate, pectic acid, galactan, starch, dextran, dextrin, alginic acid, sodium alginate, cellulose compounds Cellulose, Carboxymethylcellulose, Hydroxyethylcellulose, Hydroxypropylcellulose, Hydroxypropylcellulose, Methylcellulose), Gelatin, Agar, Celtrol, Leozan, Glycanth, Pullulan, Glycoside Compounds such as Gum arabic (Polysaccharides), Collagen, Gelatin, Fibrin, Gluten And peptide compounds (peptides, proteins) such as serum albumin; phosphate ester compounds (nucleic acids) such as deoxyribonucleic acid and ribonucleic acid; and vinyl compounds such as polyvinyl alcohol.
 基材シート2及び針山3の材料としては、同一のものを使用しても良く、別のものを使用しても良い。基材シート2を削ったりなどして針山3を形成する場合には同一材料の物が使用され、基材シート2の上にモールド成型などによって針山3を形成する場合には、別材料又は同一材料が適宜選択される。 The same material may be used as the material of the base sheet 2 and the needle pile 3, and different materials may be used. The same material is used when forming the needle pile 3 by scraping the base sheet 2 or the like, and when forming the needle pile 3 by molding or the like on the base sheet 2, another material or the same material is used. The material is appropriately selected.
 マイクロニードル1は、例えば図2に示すように、基材シート2に対して針山3を形成してから貫通孔4が形成される。針山3の形成方法としては、基材シート2に対する円偏光光渦レーザビームの照射や、モールド成型、エッチングやイオンミリングなどの各種方法が使用できる。針山3が形成された後、例えばレーザ照射やマイクロドリルによる微細孔加工などの手法によって貫通孔4が形成される。 For example, as shown in FIG. 2, in the microneedle 1, the through hole 4 is formed after the needle peak 3 is formed on the base sheet 2. As a method of forming the needle head 3, various methods such as irradiation of a circularly polarized light vortex laser beam to the substrate sheet 2, molding, etching, ion milling and the like can be used. After the needle piles 3 are formed, the through holes 4 are formed by, for example, a method such as laser irradiation or fine hole processing using a micro drill.
 また、針山3と貫通孔4とを同時に形成することもできる。例えば、図3に示すように、マイクロニードルの転写パターンを有するモールド型11と、棒状部材15と、スペーサ19とが使用される。モールド型11では、マイクロニードルの転写パターンである突起用凹部12と、当該突起用凹部12に通じモールド型11の底面(突起用凹部12の対向面)へと抜ける貫通孔4を有している。この貫通孔4は、全ての突起用凹部12に対して1つずつ設けられている。 In addition, the needle head 3 and the through hole 4 can be simultaneously formed. For example, as shown in FIG. 3, a mold 11 having a microneedle transfer pattern, a rod member 15 and a spacer 19 are used. The mold 11 has a protrusion concave portion 12 which is a transfer pattern of a microneedle, and a through hole 4 which leads to the protrusion concave portion 12 and leads to the bottom surface of the mold 11 (opposite surface of the protrusion concave portion 12). . The through holes 4 are provided one by one for all the projection recesses 12.
 棒状部材15は、貫通孔4の位置に合わせて形成された複数の棒部16と、平面状の板部17とを有しており、板部17から棒部16が突出するように固着されている。スペーサ19は、棒状部材15及びモールド型11から取り外すことができるフリー状態で存在する。 The rod-like member 15 has a plurality of rod portions 16 formed in accordance with the position of the through holes 4 and a flat plate portion 17, and is fixed so that the rod portions 16 project from the plate portion 17. ing. The spacer 19 exists in a free state that can be removed from the rod-like member 15 and the mold 11.
 図3に示すように、まず、モールド型11に対して棒状部材15が挿入されると共に、棒状部材15及びモールド型11の間にスペーサ19が挟まれる。この結果、棒状部材15及びモールド型11の間に一定の隙間空間を残した状態で、棒状部材15がモールド型11の貫通孔4を突き抜け、モールド型11から突出する。 As shown in FIG. 3, first, the rod-shaped member 15 is inserted into the mold 11, and the spacer 19 is sandwiched between the rod-shaped member 15 and the mold 11. As a result, the rod-shaped member 15 penetrates the through hole 4 of the mold 11 and protrudes from the mold 11 while leaving a certain gap space between the rod-shaped member 15 and the mold 11.
 図4に示すように、棒状部材15が挿入されたモールド型11に対し、基材シート2が充填される。基材シート2は、液状又は半液状の状態で充填される固化の方法としては、特に制限はなく、加温されて液状化した基材シート2の冷却や、低分子の基材シート2が架橋剤や硬化剤によって化学反応(高分子化)することによる硬化、結晶化、溶媒成分の蒸発などにより基材シート2が固化される。 As shown in FIG. 4, the base sheet 2 is filled into the mold 11 in which the rod-like member 15 is inserted. There is no particular limitation on the method of solidification in which the substrate sheet 2 is filled in a liquid or semi-liquid state, and the substrate sheet 2 which has been heated and liquefied is cooled, and the low molecular weight substrate sheet 2 is used. The base sheet 2 is solidified by curing, crystallization, evaporation of solvent components and the like caused by a chemical reaction (polymerization) with a crosslinking agent and a curing agent.
 固化後、モールド型11から基材シート2が離型され、成形品となる。ここで、仮に棒状部材15が挿入されたまま基材シート2を離型しようとすると、基材シート2が変形したり、棒部16が折れてしまう恐れがあるため、棒状部材15を引き抜いてから基材シート2の離型を行う。図5(A)及び(B)に示すように、まずスペーサ19を取り除き、棒状部材15をモールド型11側に一旦移動させてから、棒状部材15をモールド型11から引き抜く。そして図6に示すように、モールド型11から基材シート2を離型することにより、マイクロニードル1を製造することができる。 After solidification, the substrate sheet 2 is released from the mold 11 and becomes a molded article. Here, if it is attempted to release the substrate sheet 2 while the rod-like member 15 is inserted, the substrate sheet 2 may be deformed or the rod portion 16 may be broken, so the rod-like member 15 is pulled out. Then, the substrate sheet 2 is released. As shown in FIGS. 5A and 5B, the spacer 19 is removed first, and the rod-shaped member 15 is moved to the mold 11 side, and then the rod-shaped member 15 is pulled out from the mold 11. Then, as shown in FIG. 6, the microneedle 1 can be manufactured by releasing the base sheet 2 from the mold 11.
 また、図7に示すように、板状の台座板111,113に貫通孔112,114がそれぞれ形成されている。台座板111,113は、成形品としてのマイクロニードル1において基材シート2を構成するものであり、その材質に制限はない。 Further, as shown in FIG. 7, the through holes 112 and 114 are respectively formed in the plate- like pedestal plates 111 and 113. The base plates 111 and 113 constitute the base sheet 2 in the microneedle 1 as a molded product, and the material thereof is not limited.
 そして図8に示すように、被加工物120を突き抜けるようにして棒状部材115の棒部116が貫通され、図9に示すように、台座板103をゆっくり引き上げる(又は台座板101を引き下げる)と、台座板111,113近傍の上下(根元)部分は太くなる一方、中心付近が細くなる。この状態で被加工物110を固化させ、棒状部材105を引き抜いた後、中心部分でカットすると、図9に示すように、マイクロニードル1を製造することができる。また、中心部分が千切れるまで台座板103を引き上げて被加工物を固化させてから棒状部材105を引き抜くこともできる。 Then, as shown in FIG. 8, the rod portion 116 of the rod-like member 115 is penetrated so as to pierce the workpiece 120, and as shown in FIG. 9, the base plate 103 is slowly pulled up (or the base plate 101 is pulled down). The upper and lower (root) portions in the vicinity of the pedestal plates 111 and 113 become thicker, while the vicinity of the center becomes thinner. In this state, the workpiece 110 is solidified, and after pulling out the rod-like member 105, the microneedle 1 can be manufactured as shown in FIG. Alternatively, the rod member 105 can be pulled out after the base plate 103 is pulled up to solidify the workpiece until the central portion is broken.
 そして本願発明では、図11に示すように、シート状のマイクロニードル1の貫通孔4の端部4A又は4Bを溜めた充填液槽8に接触させ、毛細管現象によって貫通孔4に充填液9を充填する。 In the present invention, as shown in FIG. 11, the filling liquid tank 8 holding the end 4A or 4B of the through hole 4 of the sheet-like microneedle 1 is brought into contact, and the filling liquid 9 is filled in the through hole 4 by capillary action. To fill.
 毛細管現象が生じる高さは、式(1)によって表される。
Figure JPOXMLDOC01-appb-I000004
ただし、h=毛細管現象の高さ、T=表面張力(N/m)、θ=充填液と貫通孔内面との接触角(°)、ρ=充填液の密度(kg/m3)、g=重力加速度(9.80665m/sの2乗)、r=管の内径(半径:mm)
The height at which capillary action occurs is represented by equation (1).
Figure JPOXMLDOC01-appb-I000004
Where h = height of capillary action, T = surface tension (N / m), θ = contact angle between filling liquid and inner surface of through hole (°), = = density of filling liquid (kg / m 3), g = Gravity acceleration (9.80665 m / s squared), r = inside diameter of tube (radius: mm)
 従って、貫通孔高さHh≦毛細管現象の高さhであった場合、貫通孔4にはほぼ100%の充填率で充填液9が充填されることになる。また、充填率は必ずしも100%である必要性はないが、目的物質である充填液9が多く充填されていた方が好ましい。また、仮に充填率が低いと、充填液9の位置に偏りが生じて空洞ができ、充填液9が皮膚から体内に取込まれにくくなる恐れがある。そこで、貫通孔高さHh≦毛細管現象の高さh×70%であることが好ましい。 Therefore, in the case where the height h of the through hole Hh ≦ the capillary action h, the through hole 4 is filled with the filling liquid 9 at a filling rate of approximately 100%. Although the filling rate is not necessarily 100%, it is preferable that a large amount of filling liquid 9 which is the target substance be filled. In addition, if the filling rate is low, the position of the filling liquid 9 is biased to form a cavity, which may make it difficult for the filling liquid 9 to be taken into the body from the skin. Therefore, it is preferable that the through hole height Hh ≦ the height h × 70% of the capillary phenomenon.
 また、貫通孔高さHhは、好ましくは50μm以上、1000μm未満である。貫通孔高さHhが小さすぎると、針山3の先端が到達する皮膚表面からの距離が十分でなく、大きすぎると、針山3の強度が不足する可能性が生じるため好ましくない。 The through hole height Hh is preferably 50 μm or more and less than 1000 μm. If the through hole height Hh is too small, the distance from the skin surface reached by the tip of the needle pile 3 is not sufficient. If the through hole height Hh is too large, the strength of the needle pile 3 may be insufficient.
 また、充填液9(目的物質)としては、特に制限されないが、液状であり、インシュリン、ホルモン剤、抗体、ワクチンなどの各種医薬として使用される薬効成分を液状化した薬剤や、コラーゲン、ヒアルロン酸などの各種美容成分を液状化した美容液、ブドウ糖やビタミンなどの各種栄養成分を液状化した栄養液が好適に使用される。 In addition, the filling liquid 9 (target substance) is not particularly limited, but is a liquid, a drug obtained by liquefying a pharmaceutically active ingredient used as various medicines such as insulin, hormone agent, antibody, vaccine, collagen, hyaluronic acid Cosmetic solutions obtained by liquefying various cosmetic components such as, and nutrient solutions obtained by liquefying various nutritional components such as glucose and vitamins are preferably used.
 充填液9の粘度(25℃、60rpm、L型粘度計)は0.5mPa・s以上、500mPa・s以下、より好ましくは0.8mPa・s以上、200mPa・s以下であることが好ましい。粘度が低すぎると、衝撃などに対する充填液9の安定性が低下し、粘度が高すぎると、毛細管現象が生じにくくなるため好ましくない。 The viscosity (25 ° C., 60 rpm, L-type viscometer) of the filling liquid 9 is preferably 0.5 mPa · s or more and 500 mPa · s or less, more preferably 0.8 mPa · s or more and 200 mPa · s or less. If the viscosity is too low, the stability of the filling liquid 9 against impact or the like will decrease, and if the viscosity is too high, it is not preferable because the capillary phenomenon hardly occurs.
 そして図12に示すように、充填液9が充填されたマイクロニードル1は、貫通孔4の上下端が開放された状態で、保護材50に設置される。この保護材50は、基材シート2における針山3の形成されていない平坦部2Cを支持する支持部51と、底面52とを有している。支持部51は、平坦部2Cに接触すると共に、支持部51の深さDが針山3の高さHnより高く形成されており、貫通孔4の頂点に何かが接触することを防止する。これにより、貫通孔4内の充填液9が外部へ漏れ出すことを防止することができる。 Then, as shown in FIG. 12, the microneedle 1 filled with the filling liquid 9 is placed on the protective material 50 in a state in which the upper and lower ends of the through hole 4 are open. The protective material 50 has a support portion 51 for supporting the flat portion 2 </ b> C where the needle peak 3 is not formed in the base sheet 2, and a bottom surface 52. The support portion 51 is in contact with the flat portion 2C, and the depth D of the support portion 51 is formed higher than the height Hn of the needle head 3, and prevents any contact with the apex of the through hole 4. Thereby, it can prevent that the filling liquid 9 in the through-hole 4 leaks outside.
 なお、天面52は必ずしも必要ではなく、底面52の一部若しくは全部が開放されていても良い。マイクロニードル1及び保護材50における上下方向に制限はなく、上下が反転してもよい(この場合、底面52は天面となる)。 The top surface 52 is not necessarily required, and part or all of the bottom surface 52 may be open. There is no restriction in the vertical direction in the microneedle 1 and the protective material 50, and the vertical direction may be reversed (in this case, the bottom surface 52 is the top surface).
 また、貫通孔4を針山3の頂点からオフセットさせて(ずらして)形成する(図10参照)ことにより、針山3の高さを維持できると共に、針山3における貫通孔4の先端から頂点までの領域が貫通孔4を保護する役割を果たすことが可能である。さらに、図示しないが、針山3の頂点からオフセットさせると共に、貫通孔4をオフセットした方向と反対方向に傾斜させても良い。これにより、傾斜分だけ貫通孔4内部の体積を増大させることができると共に、針山3の表面から貫通孔4までの距離を極力大きくして針山3の物理的強度を保つことができる。 Further, by forming the through hole 4 offset (shifted) from the vertex of the needle peak 3 (see FIG. 10), the height of the needle peak 3 can be maintained, and the tip of the through hole 4 in the needle peak 3 to the vertex It is possible that the area serves to protect the through hole 4. Furthermore, although not shown, it may be offset from the top of the needle head 3 and inclined in the opposite direction to the offset direction of the through hole 4. Thereby, the volume inside the through hole 4 can be increased by the amount of inclination, and the physical strength of the needle peak 3 can be maintained by increasing the distance from the surface of the needle peak 3 to the through hole 4 as much as possible.
 このようにして形成されたマイクロニードル1は、頂点3Aを皮膚に刺すことにより使用される。マイクロニードル1は、皮膚に刺されると、貫通孔4の内部の充填液9が体液に接触するため、表面張力により体液に引っ張られて体内に吸収される。針山3の材料として生体吸収高分子を使用した場合には、そのままマイクロニードル1を皮膚に貼り付けたままにすることにより、針山3自体をも体内に吸収させることが可能となる. The microneedle 1 thus formed is used by piercing the apex 3A on the skin. When the microneedle 1 is pierced by the skin, the filling liquid 9 inside the through hole 4 comes in contact with the body fluid, so it is pulled by the body fluid by surface tension and absorbed into the body. In the case where a bioabsorbable polymer is used as the material of the needle pile 3, the needle pile 3 itself can be absorbed into the body by leaving the microneedle 1 stuck to the skin as it is.
 なお、ヒアルロン酸ナトリウム(ヒアルロン酸85重量%、水15重量%)で作製された厚さ300μmの平板に直径20μmの貫通孔を形成し、赤色染料液(水0.5mlに食紅0.015gを溶解させ、エタノール5mlで希釈したもの)を平板の一面に接触させたところ、赤色染料液は貫通孔内に充填されると共に、充填された状態がそのまま保持されることが実験にて確認された。 In addition, a through-hole with a diameter of 20 μm is formed in a 300 μm-thick flat plate made of sodium hyaluronate (hyaluronic acid 85 wt%, water 15 wt%), and red dye solution (water 0.5 ml with 0.015 g When dissolved and diluted with 5 ml of ethanol was brought into contact with one side of a flat plate, the red dye solution was filled in the through hole and it was confirmed by experiment that the filled state is maintained as it is .
<動作及び効果>
 以下、上記した実施形態から抽出される発明群の特徴について、必要に応じて課題及び効果等を示しつつ説明する。なお以下においては、理解の容易のため、上記各実施形態において対応する構成を括弧書き等で適宜示すが、この括弧書き等で示した具体的構成に限定されるものではない。また、各特徴に記載した用語の意味や例示等は、同一の文言にて記載した他の特徴に記載した用語の意味や例示として適用しても良い。
<Operation and effect>
Hereinafter, the features of the invention group extracted from the above-described embodiment will be described by showing problems, effects, and the like as necessary. In the following, for ease of understanding, the corresponding configurations in the above-described embodiments are appropriately shown in parentheses, but the present invention is not limited to the specific configurations shown in parentheses. In addition, the meanings and examples of the terms described in the respective features may be applied as the meanings and examples of the terms described in the other features described in the same word.
 本発明のマイクロニードルの製造方法では、複数の針山(針山3)が形成されており、該針山が形成されたシート表面(シート表面2A)側からシート裏面(シート裏面2B)側までまでを貫通する貫通孔(貫通孔4)が形成されているシート状のマイクロニードル(マイクロニードル1)の貫通孔端部を充填液(充填液9)に接触させ、毛細管現象によって貫通孔に充填液を充填する。なお、シート表面側とは、針山部分及び針山が形成されていない平面部分を合わせた全ての面をいう。 In the method of manufacturing a microneedle according to the present invention, a plurality of needle piles (needle piles 3) are formed, and they are penetrated from the sheet surface (sheet front surface 2A) side where the needle piles are formed to the sheet back surface (sheet back surface 2B) side The end of the through hole of the sheet-like microneedle (microneedle 1) in which the through hole (through hole 4) is formed is brought into contact with the filling liquid (filling liquid 9), and the through hole is filled with the filling liquid Do. In addition, the sheet | seat surface side means all the surfaces which united the needle-peak part and the plane part in which the needle-peak is not formed.
 これにより、簡易な方法で充填液を充填してマイクロニードルの製造を簡易にすることができる。 Thereby, the filling liquid can be filled by a simple method, and the manufacture of the microneedle can be simplified.
 h=毛細管現象の高さ、T=表面張力(N/m)、θ=充填液と貫通孔内面との接触角(°)、ρ=充填液の密度(kg/m3)、g=重力加速度(9.80665m/sの2乗)、r=管の内径(半径:mm)としたとき、式(1)として表される毛細管現象の高さhは、貫通孔高さHhの70%以上である h = height of capillary action, T = surface tension (N / m), θ = contact angle between filling liquid and inner surface of through hole (°), ρ = density of filling liquid (kg / m 3), g = gravitational acceleration (Height of square of 9.80665 m / s), r = inner diameter of tube (radius: mm), the height h of the capillary phenomenon expressed as the equation (1) is 70% or more of the through hole height Hh is there
 これにより、貫通孔4内部に充填される充填液の充填率を高めることができると共に、貫通孔4内部の空洞(空気含有)率を低下させて連続性を高めることができるため、針山が皮膚に入れられたときに、空気によって止まることなくスムーズに充填液を注入させることができる。 As a result, the filling rate of the filling liquid to be filled in the through hole 4 can be increased, and the void (air content) rate in the through hole 4 can be reduced to improve the continuity. When put in, the filling liquid can be injected smoothly without stopping by air.
 前記針山の頂点側を前記充填液に接触させることにより、シート裏面側を充填液に接触させる方法と比較して、充填液に対して接触する部分が少なく済み、余分な充填液液を付着させずに済む。 By contacting the top side of the needle pile with the filling liquid, the portion contacting the filling liquid is reduced compared to the method in which the back side of the sheet is in contact with the filling liquid, and excess filling liquid is deposited It is not necessary.
 前記マイクロニードルは、前記針山に対して、前記針山の先端方向から照射されるレーザを用いて前記貫通孔が形成されたことを特徴とする。これにより、貫通孔を任意の径で容易にかつ速やかに形成することができると共に、レーザによって熔解させた成分を貫通孔の周囲に付着させて盛り上がりを形成し、当該盛り上がりによって外部との接触を防止できるため貫通孔内部の充填液を保護する役割を果たすことができる。 The microneedle is characterized in that the through hole is formed by using a laser which is irradiated from the tip direction of the needle pile to the needle pile. As a result, the through hole can be formed easily and quickly with an arbitrary diameter, and the component melted by the laser is attached to the periphery of the through hole to form a bulge, and the bulge makes contact with the outside. Since it can prevent, it can play a role which protects the filling liquid inside a through-hole.
 前記マイクロニードルは、針山形成時において、予め貫通された棒状部材を引き抜くことにより前記貫通孔が形成され、前記棒状部材は、前記針山の根元方向へ引き抜かれたことを特徴とする。これにより、根元部分が盛り上がり、当該盛り上がりによって外部との接触を防止できるため貫通孔内部の充填液を保護する役割を果たすことができる。 The microneedle is characterized in that the through hole is formed by pulling out a rod-like member which has been penetrated in advance when forming the needle peak, and the rod-like member is drawn in the direction of the root of the needle peak. As a result, the root portion is swelled, and contact with the outside can be prevented by the swell, which can play a role of protecting the filling liquid in the through hole.
 前記貫通孔は、前記頂点から所定のオフセット量だけずらした位置に形成されていることにより、頂点が貫通孔を保護する役割を果たすことができる。なお、オフセット量に制限は無いが、針山の半径の1/4以上のオフセット量を確保することにより、針山頂点近傍の強度を維持できる。また、針山の半径の2.0倍未満、より好ましくは1.5倍未満に設定することにより、充填液を確実に皮膚内に導入することが可能である。なおオフセット量とは、針山頂点から貫通孔の中心までの平面距離(シート表面の平面部分に平行な距離)とする。また針山の半径とは、針山頂点からの斜面部分に沿う稜線とシート表面の平面を延長した平面線との交点から針山頂点までの距離とする。針山頂点が針山において完全な中心位置にない場合には、平均値を半径とみなすものとする。 By forming the through holes at positions offset from the apexes by a predetermined offset amount, the apexes can play a role in protecting the through holes. Although the amount of offset is not limited, the strength in the vicinity of the tip of the needle peak can be maintained by securing the offset amount of 1⁄4 or more of the radius of the needle tip. Also, by setting the radius of the needle to less than 2.0 times, more preferably less than 1.5 times, it is possible to reliably introduce the filling solution into the skin. The offset amount is a plane distance (a distance parallel to a plane portion of the sheet surface) from the needle peak to the center of the through hole. Further, the radius of the needle peak is the distance from the intersection of the ridge line along the slope portion from the needle peak and the plane line extending the plane of the sheet surface to the needle peak. If the needle peak is not at the perfect center position of the needle peak, the average value is regarded as the radius.
 貫通孔の高さhは、50μm以上、1000μm未満であることにより、皮膚に注射するのに適したマイクロニードルを提供することができる。 When the height h of the through hole is 50 μm or more and less than 1000 μm, a microneedle suitable for injection into the skin can be provided.
 前記充填液の粘度は、0.5mPa・s以上、500mPa・s以下であることにより、毛細管現象を生じさせつつ貫通孔内部に充填液を安定的に保持し得る。 When the viscosity of the filling liquid is 0.5 mPa · s or more and 500 mPa · s or less, the filling liquid can be stably held inside the through hole while causing capillary phenomenon.
 前記貫通孔は、前記針山の根元部分の近傍に形成されている。これにより、針山が形成されていない平面部分に貫通孔を設ければ良いため、針山の強度を維持できる。 The through hole is formed in the vicinity of the root portion of the needle peak. As a result, since it is sufficient to provide the through hole in the flat portion where the needle pile is not formed, the strength of the needle pile can be maintained.
 前記シートに対向する対向面と、前記対向面から突出して形成され、前記シート表面から針山の頂点までの針山高さよりも高く形成された支持部(支持部51)とを有する保護材(保護材50)を、
 前記支持部の頂点と、前記シートにおける前記針山の形成されていない平坦部とが接触するように配置することを特徴とする。
Protective material (protective material) having a facing surface facing the sheet and a supporting portion (supporting portion 51) which is formed to protrude from the facing surface and is formed to be higher than the needle peak height from the sheet surface to the top of the needle peak 50),
It arrange | positions so that the vertex of the said support part and the flat part in which the said needle | hook in the said sheet | seat may not be formed may contact.
 これにより、貫通孔の先端が接触しないようにマイクロニードルを適切に保護することができる。 Thereby, the microneedle can be appropriately protected so that the tip of the through hole does not contact.
 前記貫通孔における2つの端部は、開放されていることにより、製造工程を簡易にできる。 The two ends of the through hole are open, which can simplify the manufacturing process.
 また、マイクロニードルは、針山の頂点側を皮膚に刺し、皮膚内部の体液と接触させることにより、表面張力を用いて充填液を体内に吸収させる。これにより、マイクロニードルは、特段加圧などを要することなく簡単な手順でユーザの体内に目的物質を吸収させることができる。 In addition, the microneedle pierces the skin at the top of the needle peak and contacts the body fluid inside the skin, thereby using surface tension to absorb the filling fluid into the body. Thus, the microneedle can absorb the target substance into the user's body in a simple procedure without requiring special pressurization or the like.
 さらに、図13に示すように、マイクロニードル2の使用直前に充填液9を貫通孔4の内部に充填することも可能である。この場合、保護材150は、支持部151の底部又は底部近傍において支持部150間を貫通する孔155が設けられている。ユーザは保護材150に別添付された、若しくは自身が保有している美容液や化粧水、専用液などの充填液9を保護材150に流し入れると、孔155を介して保護材150の全域に充填液9が行き渡り、充填液槽8が形成される。 Furthermore, as shown in FIG. 13, it is also possible to fill the inside of the through hole 4 with the filling liquid 9 immediately before using the microneedle 2. In this case, the protective material 150 is provided with a hole 155 penetrating between the support portions 150 at or near the bottom portion of the support portion 151. When the user pours into the protective material 150 a filling solution 9 such as a cosmetic solution, a cosmetic solution, or a special solution which is separately attached to the protective material 150 or held by the user, the entire area of the protective material 150 is formed through the holes 155. The filling liquid 9 spreads to form the filling liquid tank 8.
 この保護材150における支持部151の深さDは針山3の高さHhよりも僅かに大きく形成されて(例えば0.05~0.5mm)いる。従って、ユーザが保護材150に充填液9を流し入れ、マイクロニードル1を載置するだけで、針山3の頂点3Aが底面152に接触することがなく位置決めされ、ユーザは簡単に頂点3Aを充填液槽8に接触させてマイクロニードル1の貫通孔4内部に充填液9を充填することができる。 The depth D of the support portion 151 in the protective material 150 is formed slightly larger than the height Hh of the needle head 3 (for example, 0.05 to 0.5 mm). Therefore, just by the user pouring the filling liquid 9 into the protective material 150 and mounting the microneedle 1, the apex 3A of the needle pile 3 is positioned without coming into contact with the bottom surface 152, and the user can easily fill the apex 3A with the filling liquid The filling liquid 9 can be filled in the through hole 4 of the microneedle 1 by contacting the tank 8.
 すなわち、保護材150における支持部151の深さDは針山3の高さHhよりも僅かに大きく形成すると共に、支持部151間を液体が行き来できるように孔又は支持部151に間隙を設ける。これにより、充填液9を保護材151の全域に行き渡らせて充填液槽8を形成できると共に、支持部151によって頂点3Aの位置を底面152より僅かに上の位置に配置させ、毛細管現象によって充填液9を簡単に充填させることができる。 That is, the depth D of the support portion 151 in the protective material 150 is formed to be slightly larger than the height Hh of the needle head 3, and a hole is provided in the hole or the support portion 151 so that the liquid can move between the support portions 151. As a result, the filling liquid 9 can be spread over the entire area of the protective material 151 to form the filling liquid tank 8, and the position of the apex 3A is positioned slightly above the bottom surface 152 by the support portion 151, and filling is performed by capillary action. The liquid 9 can be easily filled.
 また、図14に示すように、マイクロニードル1のシート裏面2B側から充填液9を吸上げることもできる。この場合、例えば平らなトレイ250の中心付近に規定量の充填液を滴下し、これを充填槽8とする。マイクロニードル1を折り曲げながら中心近傍が充填槽8に最初に接触するようにマイクロニードル1をセットし、空気が入らないように気をつけながら外側が徐々にトレイ250に接触するようにしてマイクロニードル1をトレイ250上に載置する。これにより、充填槽8がマイクロニードル1の全域に広がり、毛細管現象によって貫通孔4の内部に充填液9を充填することができる。なお、図14では、液漏れ防止用途でトレイ250に底面252から盛り上がる外枠251が形成されているが、必ずしも必須ではない。このトレイ250は、マイクロニードル1の先端3Aを保護する保護材と兼用されても良く、別添付や別売りにされていても良い。 Further, as shown in FIG. 14, the filling liquid 9 can be sucked up from the back surface 2 B side of the microneedle 1. In this case, for example, a predetermined amount of filling liquid is dropped near the center of the flat tray 250, and this is used as the filling tank 8. Set the microneedle 1 so that the vicinity of the center makes contact with the filling tank 8 first while bending the microneedle 1, and make sure that the outer side gradually contacts the tray 250 while taking care not to enter air. 1 is placed on the tray 250. As a result, the filling tank 8 spreads over the entire area of the microneedle 1, and the inside of the through hole 4 can be filled with the filling liquid 9 by capillary action. In FIG. 14, although the outer frame 251 rising from the bottom surface 252 is formed on the tray 250 for the purpose of liquid leakage prevention, it is not necessarily essential. The tray 250 may be used as a protective material for protecting the tip 3A of the microneedle 1, and may be separately attached or sold separately.
 また、図15に示すように、針山2の根元部分の近傍、すなわち針山の先端からのオフセット量を針山2の半径よりも大きくかつ針山2の半径の2倍未満、より好ましくは1.5倍未満に設定するように貫通孔4Xを設けても良い。言い換えると、針山のすぐ横に貫通孔が形成されている。この場合であっても、針山2によって皮膚に傷をつけたところに貫通孔4Xに充填した充填液を供給できるため、針山に貫通孔を設けた場合と同様の効果(皮膚への充填液の浸透)を得ることができる。なお、貫通孔4Xは、針山が形成される前又は後、もしくは針山と同時に形成されることができる。モールド成形により針山が形成される場合には、金型における針山のない位置に貫通孔を設け、棒状部材を貫通させれば良い。 Further, as shown in FIG. 15, the offset amount from the vicinity of the root portion of the needle head 2, that is, the offset from the tip of the needle head is larger than the radius of the needle head 2 and less than twice the radius of the needle head 2, more preferably 1.5 times You may provide the through-hole 4X so that it may set to less than. In other words, a through hole is formed immediately next to the needle pile. Even in this case, the filling liquid filled in the through hole 4X can be supplied where the skin is scratched by the needle head 2. Therefore, the same effect as in the case where the through hole is provided in the needle head Penetration) can be obtained. The through holes 4X can be formed before or after the formation of the needle pile, or simultaneously with the needle pile. When a needle pile is formed by molding, a through hole may be provided at a position where there is no needle pile in the mold, and the rod-like member may be penetrated.
 また、マイクロニードル1のシート裏面2B上に充填液を滴下してへらなどを用いて広げることにより充填液9を充填することもできる。 Alternatively, the filling liquid 9 can be filled by dropping the filling liquid onto the back surface 2B of the microneedle 1 and spreading it using a spatula or the like.
 本発明は、例えば注射用途でのマイクロニードルに適用することができる。 The present invention can be applied to microneedles, for example in injection applications.
1   :マイクロニードル
2   :基材シート
2A  :シート表面
2B  :シート裏面
2C  :平坦部
3   :針山
3A  :頂点
4   :貫通孔
4A  :端部
8   :充填液槽
9   :充填液

 
DESCRIPTION OF SYMBOLS 1: Microneedle 2: Base sheet 2A: Sheet surface 2B: Sheet back surface 2C: Flat part 3: Needle peak 3A: Vertex 4: Through hole 4A: End part 8: Filling liquid tank 9: Filling liquid

Claims (14)

  1.  複数の針山が形成されており、該針山が形成されたシート表面側からシート裏面側までを貫通する貫通孔が形成されているシート状のマイクロニードルの貫通孔端部を充填液に接触させ、毛細管現象によって貫通孔に充填液を充填する
     ことを特徴とするマイクロニードルの製造方法。
    A plurality of needle peaks are formed, and the end of the through hole of the sheet-like microneedle in which the through hole penetrating from the sheet surface side to the sheet back side where the needle peaks are formed is formed is brought into contact with the filling liquid A method of manufacturing a microneedle, characterized in that the through hole is filled with a filling liquid by capillary action.
  2.  h=毛細管現象の高さ、T=表面張力(N/m)、θ=充填液と貫通孔内面との接触角(°)、ρ=充填液の密度(kg/m3)、g=重力加速度(9.80665m/sの2乗)、r=管の内径(半径:mm)としたとき、式(1)として表される毛細管現象の高さhは、前記貫通孔の高さHhの70%以上である
    Figure JPOXMLDOC01-appb-I000001
     ことを特徴とする請求項1に記載のマイクロニードルの製造方法。
    h = height of capillary action, T = surface tension (N / m), θ = contact angle between filling liquid and inner surface of through hole (°), ρ = density of filling liquid (kg / m 3), g = gravitational acceleration (Height of square of 9.80665 m / s), r = inner diameter of tube (radius: mm), height h of capillary phenomenon expressed as equation (1) is 70% of height Hh of the through hole More than
    Figure JPOXMLDOC01-appb-I000001
    The method for producing a microneedle according to claim 1, characterized in that:
  3.  前記針山の頂点側を前記充填液に接触させる
     ことを特徴とする請求項1又は請求項2のいずれかに記載のマイクロニードルの製造方法。
    The method for manufacturing a microneedle according to any one of claims 1 and 2, wherein the top side of the needle crest is brought into contact with the filling solution.
  4.  前記マイクロニードルは、
     前記針山に対して、前記針山の先端方向から照射されるレーザを用いて前記貫通孔が形成された
     ことを特徴とする請求項1~請求項3のいずれかに記載のマイクロニードルの製造方法。
    The microneedle is
    The method for manufacturing a microneedle according to any one of claims 1 to 3, wherein the through hole is formed with respect to the needle pile using a laser irradiated from the tip direction of the needle pile.
  5.  前記マイクロニードルは、
     針山形成時において、予め貫通された棒状部材を引き抜くことにより前記貫通孔が形成され、
     前記棒状部材は、前記針山の根元方向へ引き抜かれた
     ことを特徴とする請求項1~請求項3のいずれかに記載のマイクロニードルの製造方法。
    The microneedle is
    At the time of needle formation, the through hole is formed by pulling out the rod-like member which has been penetrated in advance.
    The method for manufacturing a microneedle according to any one of claims 1 to 3, wherein the rod-like member is pulled out in the direction of the root of the needle peak.
  6.  前記貫通孔は、
     前記頂点近傍から所定のオフセット量だけずらした位置に形成されている
     ことを特徴とするに請求項1~請求項5のいずれかに記載のマイクロニードルの製造方法。
    The through hole is
    The method for manufacturing a microneedle according to any one of claims 1 to 5, wherein the microneedle is formed at a position shifted by a predetermined offset amount from the vicinity of the vertex.
  7.  貫通孔の高さhは、50μm以上、1000μm未満である
     ことを特徴とする請求項1~請求項6のいずれかに記載のマイクロニードルの製造方法。
    The method for producing a microneedle according to any one of claims 1 to 6, wherein the height h of the through hole is 50 μm or more and less than 1000 μm.
  8.  前記充填液の粘度は、0.5mPa・s以上、500mPa・s以下である
     ことを特徴とする請求項1~請求項7のいずれかに記載のマイクロニードルの製造方法。
    The method for producing a microneedle according to any one of claims 1 to 7, wherein the viscosity of the filling liquid is 0.5 mPa · s or more and 500 mPa · s or less.
  9.  前記シートに対向する対向面と、前記対向面から突出して形成され、前記シート表面から針山の頂点までの針山高さよりも高く形成された支持部とを有する保護材を、
     前記支持部の頂点と、前記シートにおける前記針山の形成されていない平坦部とが接触するように配置する
     ことを特徴とする請求項1~請求項7のいずれかに記載のマイクロニードルの製造方法。
    A protective material having a facing surface facing the sheet, and a supporting portion formed protruding from the facing surface and formed higher than the needle peak height from the sheet surface to the top of the needle peak,
    The microneedle manufacturing method according to any one of claims 1 to 7, wherein the apex of the support portion is arranged to be in contact with the flat portion on which the needle crests are not formed in the sheet. .
  10.  前記貫通孔における2つの端部は、開放されている
     ことを特徴とする請求項1~請求項8のいずれかに記載のマイクロニードルの製造方法。
    The method for manufacturing a microneedle according to any one of claims 1 to 8, wherein two ends of the through hole are open.
  11.  前記貫通孔は、
     前記針山の根元部分の近傍に形成されている
     ことを特徴とする請求項1に記載のマイクロニードルの製造方法。
    The through hole is
    The method for manufacturing a microneedle according to claim 1, wherein the microneedle is formed in the vicinity of a root portion of the needle peak.
  12.  複数の針山が形成されており、それぞれの針山の頂点又は頂点近傍からシート裏面までを貫通する貫通孔が形成されており、貫通孔内には充填液が充填されており、
     h=貫通孔の高さ、T=表面張力(N/m)、θ=充填液と貫通孔内面との接触角(°)、ρ=充填液の密度(kg/m3)、g=重力加速度(9.80665m/sの2乗)、r=管の内径(半径:mm)としたとき、式(1)として表される毛細管現象の高さhは、前記貫通孔の高さHhの70%以上である
    Figure JPOXMLDOC01-appb-I000002
     ことを特徴とするマイクロニードル。
    A plurality of needle piles are formed, and a through hole penetrating from the vertex or apex vicinity of each needle pile to the back surface of the sheet is formed, and the through hole is filled with the filling liquid,
    h = height of through hole, T = surface tension (N / m), θ = contact angle between filling solution and inner surface of through hole (°), = = density of filling solution (kg / m 3), g = gravitational acceleration (Height of square of 9.80665 m / s), r = inner diameter of tube (radius: mm), height h of capillary phenomenon expressed as equation (1) is 70% of height Hh of the through hole More than
    Figure JPOXMLDOC01-appb-I000002
    A microneedle characterized by
  13.  針山の頂点側を皮膚に刺し、皮膚内部の体液と接触させることにより、表面張力を用いて充填液を体内に吸収させる
     ことを特徴とする請求項11に記載のマイクロニードル。
    The microneedle according to claim 11, characterized in that the filling liquid is absorbed into the body using surface tension by piercing the skin on the top side of the needle pile and contacting the body fluid inside the skin.
  14.  複数の針山が形成されており、それぞれの針山の頂点又は頂点近傍からシート裏面までを貫通する貫通孔が形成され、前記貫通孔に充填液が充填されたシート状のマイクロニードルにおける前記貫通孔の先端部を皮膚に刺し、皮膚内部の体液と接触させることにより、表面張力を用いて充填液を体内に吸収させる
     ことを特徴とするマイクロニードルの使用方法。

     
    A plurality of needle piles are formed, and a through hole is formed from the apex of each needle pile or from the vicinity of the apex to the back surface of the sheet, and the through hole in the sheet-like microneedle filled with filling liquid in the through hole A method of using a microneedle characterized in that the tip portion is pierced in the skin and brought into contact with the body fluid inside the skin to absorb the filling liquid into the body using surface tension.

PCT/JP2018/034766 2017-09-20 2018-09-20 Method for manufacture of microneedle and microneedle WO2019059265A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019543695A JPWO2019059265A1 (en) 2017-09-20 2018-09-20 Microneedle sheet and method for manufacturing microneedle sheet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017179813 2017-09-20
JP2017-179813 2017-09-20

Publications (1)

Publication Number Publication Date
WO2019059265A1 true WO2019059265A1 (en) 2019-03-28

Family

ID=65809775

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/034766 WO2019059265A1 (en) 2017-09-20 2018-09-20 Method for manufacture of microneedle and microneedle

Country Status (2)

Country Link
JP (1) JPWO2019059265A1 (en)
WO (1) WO2019059265A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114939229A (en) * 2021-02-17 2022-08-26 株式会社Gl Microneedle assembly
JP7522006B2 (en) 2020-10-29 2024-07-24 花王株式会社 Manufacturing method of hollow protruding tool

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2522309A (en) * 1948-12-01 1950-09-12 Frank A Simon Allergy testing instrument
JP2001149485A (en) * 1999-09-22 2001-06-05 Becton Dickinson & Co Method and device for percutaneous dosage of substance
JP2004504120A (en) * 2000-07-21 2004-02-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム vaccine
US20080058726A1 (en) * 2006-08-30 2008-03-06 Arvind Jina Methods and Apparatus Incorporating a Surface Penetration Device
WO2015190098A1 (en) * 2014-06-13 2015-12-17 凸版印刷株式会社 Needle-shaped body manufacturing method and needle-shaped body
WO2016147476A1 (en) * 2015-03-18 2016-09-22 凸版印刷株式会社 Drug administration device, and manufacturing method for drug administration device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008020632A1 (en) * 2006-08-18 2008-02-21 Toppan Printing Co., Ltd. Microneedle and microneedle patch
JP2013153959A (en) * 2012-01-30 2013-08-15 Toppan Printing Co Ltd Structure of needle shape body
WO2015125475A1 (en) * 2014-02-24 2015-08-27 凸版印刷株式会社 Hollow needle-shaped body manufacturing method and hollow needle-shaped body

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2522309A (en) * 1948-12-01 1950-09-12 Frank A Simon Allergy testing instrument
JP2001149485A (en) * 1999-09-22 2001-06-05 Becton Dickinson & Co Method and device for percutaneous dosage of substance
JP2004504120A (en) * 2000-07-21 2004-02-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム vaccine
US20080058726A1 (en) * 2006-08-30 2008-03-06 Arvind Jina Methods and Apparatus Incorporating a Surface Penetration Device
WO2015190098A1 (en) * 2014-06-13 2015-12-17 凸版印刷株式会社 Needle-shaped body manufacturing method and needle-shaped body
WO2016147476A1 (en) * 2015-03-18 2016-09-22 凸版印刷株式会社 Drug administration device, and manufacturing method for drug administration device

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7522006B2 (en) 2020-10-29 2024-07-24 花王株式会社 Manufacturing method of hollow protruding tool
CN114939229A (en) * 2021-02-17 2022-08-26 株式会社Gl Microneedle assembly
JP2022125986A (en) * 2021-02-17 2022-08-29 ジーエル カンパニー カンパニー リミテッド microneedle assembly
JP7330317B2 (en) 2021-02-17 2023-08-21 ジーエル カンパニー カンパニー リミテッド microneedle assembly
CN114939229B (en) * 2021-02-17 2024-02-02 株式会社Gl Microneedle assembly

Also Published As

Publication number Publication date
JPWO2019059265A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
JP5419702B2 (en) Microneedle device
JP6369026B2 (en) Microneedle and method for manufacturing microneedle
WO2010140401A1 (en) Microneedle array using porous substrate and process for producing same
US10363406B2 (en) Method for producing acicular body
US10918845B2 (en) Transdermal administration device
SG173160A1 (en) Microneedle device
CN108697882A (en) Utilize the preparation method of the micropin of biocompatibility macromolecule
JP6323975B2 (en) Manufacturing method of needle-shaped body
WO2019059265A1 (en) Method for manufacture of microneedle and microneedle
JP2016030072A (en) Microneedle array
JP7020399B2 (en) Transdermal administration device
JP6421393B1 (en) Manufacturing method of microneedle
JP5852280B1 (en) Microneedle and its manufacture
JP2009233808A (en) Hollow needle sheet and manufacturing method for the same
TW202003029A (en) Japanese-encephalitis-vaccine-containing microneedle array
JP2013111104A (en) Method for manufacturing microneedle device
JP6643793B2 (en) Method for producing hollow needle-shaped body
WO2020067102A1 (en) Mold, and method for producing transdermal absorption sheet
CA3143920A1 (en) Microneedle array having uneven needle density
JP6060547B2 (en) Manufacturing method of needle-shaped body
CN219517547U (en) Novel inclined microneedle structure
TWI631965B (en) Microneedle device and its manufacturing method
JP2019092846A (en) Transdermal administration device and using method of transdermal administration device
TW202103731A (en) Microneedle array and method for manufacturing microneedle array
JP5990913B2 (en) Manufacturing method of needle-shaped body

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18858263

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019543695

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18858263

Country of ref document: EP

Kind code of ref document: A1